About PerkinElmer Genetics
Turning Complexity into Meaning
PerkinElmer Genetics, a state-of-the-art biochemical and molecular screening laboratory, provides one of the world’s most comprehensive programs for detecting clinically significant inherited disorders. Our services are designed to identify treatable disorders before irreversible health damage occurs. Since our founding in 1994, we have analyzed blood samples from more than six million newborns.
Our staff of more than 50 dedicated employees, with extensive experience in all aspects of newborn and genetic screening, includes genetic counselors, laboratory scientists certified by the American Board of Medical Genetics and the American Board of Bioanalysis, and renowned experts in tandem mass spectrometry and next-generation sequencing. This combined knowledge and expertise is enhanced by a panel of academic and clinical advisors and consultants, and by our background as part of PerkinElmer, Inc., a global life-sciences company recognized as the leader in newborn screening research and development worldwide.
Our laboratory is accredited by the College of American Pathologists, the Centers for Medicare and Medicaid Services in compliance with the Clinical Laboratory Improvement Amendments, the Joint Commission of Healthcare Organizations, and the Commission for Office Laboratory Accreditation. PerkinElmer Genetics also participates in the Newborn Screening Quality Assurance Program administered by the Centers for Disease Control and Prevention.
PerkinElmer Genetics provides screening programs and genetic testing across the United States and around the world including several state mandated programs in the United States. We also provide inherited disease screening and confirmatory testing services to the pharmaceutical and biotech industry.
PerkinElmer Genetics in the News
- Neuromuscular Disease Foundation (NDF) Launches Whole Genome Sequencing Research for Rare Muscle Disease
- PerkinElmer and In-Depth Genomics Team Up for Whole Genome Sequencing Diagnostic Program for Rare Diseases
- PerkinElmer Launches Clinical Whole Genome Sequencing Services
- PerkinElmer Extends Clinical Whole Genome Sequencing Services
Normal Business Hours
Client Services Department
Monday thru Friday 8 AM Eastern to 5 PM Eastern
Toll Free: 1-866-463-6436
Form: Contact us via web form